Exploring the Influence of Carbon Nanoparticles on the Formation of β-Sheet-Rich Oligomers of IAPP22-28 Peptide by Molecular Dynamics Simulation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Guo, Jingjing ^a,b   Li, Jiazhong ^a   Zhang, Yan ^a   Jin, Xiaojie ^b   Liu, Huanxiang ^a,b   Yao, Xiaojun ^b  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOPARTICLE; FULLERENE; GRAPHENE; ISLET AMYLOID POLYPEPTIDE FRAGMENT[22-28]; NANOMATERIAL; NANOPARTICLE; OLIGOMER; POLYPEPTIDE; SINGLE WALLED NANOTUBE; UNCLASSIFIED DRUG; AMYLIN; CARBON NANOTUBE; PEPTIDE FRAGMENT;

ADSORPTION KINETICS; ARTICLE; BETA SHEET; BINDING AFFINITY; BINDING SITE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR SIZE; NANOANALYSIS; PEPTIDE ANALYSIS; PROTEIN AGGREGATION; STRUCTURE ANALYSIS; SURFACE PROPERTY; CHEMICAL PHENOMENA; CHEMISTRY; HUMAN; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE;

HUMANS; HYDROGEN BONDING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; ISLET AMYLOID POLYPEPTIDE; MOLECULAR DYNAMICS SIMULATION; NANOTUBES, CARBON; PEPTIDE FRAGMENTS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; SURFACE PROPERTIES;

EID: 84878769440     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065579     Document Type: Article

References (63)

1. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AKR, Han MS, et al. (2006) Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation. Science 312: 1027-1030.
2. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, et al. (2005) Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics. Science 307: 538-544.
3. Wang X, Yang L, Chen Z, Shin DM, (2008) Application of Nanotechnology in Cancer Therapy and Imaging. CA Cancer J Clin 58: 97-110.
4. Elsaesser A, Howard CV, (2012) Toxicology of nanoparticles. Adv Drug Del Rev 64: 129-137.
5. Sharifi S, Behzadi S, Laurent S, Laird Forrest M, Stroeve P, et al. (2012) Toxicity of nanomaterials. Chem Soc Rev 41: 2323-2343.
6. Gilbert N, (2009) Nanoparticle safety in doubt. Nature 460: 937-937.
7. Nel A, Xia T, Mädler L, Li N, (2006) Toxic Potential of Materials at the Nanolevel. Science 311: 622-627.
8. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, et al. (2011) Protein-Nanoparticle Interactions: Opportunities and Challenges. Chem Rev 111: 5610-5637.
9. Stefani M, (2007) Generic Cell Dysfunction in Neurodegenerative Disorders: Role of Surfaces in Early Protein Misfolding, Aggregation, and Aggregate Cytotoxicity. Neuroscientist 13: 519-531.
10. Shemetov AA, Nabiev I, Sukhanova A, (2012) Molecular Interaction of Proteins and Peptides with Nanoparticles. ACS nano 6: 4585-4602.
11. Lee C-M, Huang S-T, Huang S-H, Lin H-W, Tsai H-P, et al. (2011) C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide. Nanomed: Nanotechnol 7: 107-114.
12. Bobylev A, Marsagishvili L, Podlubnaya Z, (2010) Fluorescence analysis of the action of soluble derivatives of fullerene C60 on amyloid fibrils of the brain peptide Aβ(1-42). Biophysics 55: 699-702.
13. Podlubnaya Z, Podol'skii I, Shpagina M, Marsagishvili L, (2006) Electron microscopic study of the effect of fullerene on the formation of amyloid fibrils by the Aβ25-35 peptide. Biophysics 51: 701-704.
14. Kim JE, Lee M, (2003) Fullerene inhibits β-amyloid peptide aggregation. Biochem Biophys Res Commun 303: 576-579.
15. Linse S, Cabaleiro-Lago C, Xue W-F, Lynch I, Lindman S, et al. (2007) Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci 104: 8691-8696.
16. Li H, Luo Y, Derreumaux P, Wei G, (2011) Carbon Nanotube Inhibits the Formation of β-Sheet-Rich Oligomers of the Alzheimer's Amyloid-β(16-22) Peptide. Biophys J 101: 2267-2276.
17. Kowalewski T, Holtzman DM, (1999) In situ atomic force microscopy study of Alzheimer's β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation. Proc Natl Acad Sci 96: 3688-3693.
18. Mahmoudi M, Akhavan O, Ghavami M, Rezaee F, Ghiasi SMA, (2012) Graphene oxide strongly inhibits amyloid beta fibrillation. Nanoscale 4: 7322-7325.
19. Cabaleiro-Lago C, Szczepankiewicz O, Linse S, (2012) The Effect of Nanoparticles on Amyloid Aggregation Depends on the Protein Stability and Intrinsic Aggregation Rate. Langmuir 28: 1852-1857.
20. Dobson CM, (2003) Protein folding and misfolding. Nature 426: 884-890.
21. Chiti F, Dobson C, (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366.
22. Stefani M, (2010) Protein Aggregation Diseases: Toxicity of Soluble Prefibrillar Aggregates and Their Clinical Significance. Methods Mol Biol 648: 25-41.
23. Stefani M, Dobson CM, (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81: 678-699.
24. Glabe CG, (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27: 570-575.
25. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis. Science 300: 486-489.
26. Meier JJ, Kayed R, Lin C-Y, Gurlo T, Haataja L, et al. (2006) Inhibition of human IAPP fibril formation does not prevent β-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metabol 291: E1317-E1324.
27. Wei L, Jiang P, Xu W, Li H, Zhang H, et al. (2011) The molecular basis of distinct aggregation pathways of islet amyloid polypeptide. J Biol Chem 286: 6291-6300.
28. Haataja L, Gurlo T, Huang CJ, Butler PC, (2008) Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis. Endocr Rev 29: 303-316.
29. Ritzel RA, Meier JJ, Lin C-Y, Veldhuis JD, Butler PC, (2007) Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets. Diabetes 56: 65-71.
30. Lin C-Y, Gurlo T, Kayed R, Butler AE, Haataja L, et al. (2007) Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP-Induced β-Cell Apoptosis in h-IAPP Transgenic Mice. Diabetes 56: 1324-1332.
31. Liu G, Garrett MR, Men P, Zhu X, Perry G, et al. (2005) Nanoparticle and other metal chelation therapeutics in Alzheimer disease. BBA-Mol Basis Dis 1741: 246-252.
32. Sahni JK, Doggui S, Ali J, Baboota S, Dao L, et al. (2011) Neurotherapeutic applications of nanoparticles in Alzheimer's disease. J Control Release 152: 208-231.
33. Xiao L, Zhao D, Chan W-H, Choi MMF, Li H-W, (2010) Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-l-cysteine capped quantum dots. Biomaterials 31: 91-98.
34. Chan HM, Xiao L, Yeung KM, Ho SL, Zhao D, et al. (2012) Effect of surface-functionalized nanoparticles on the elongation phase of beta-amyloid (1-40) fibrillogenesis. Biomaterials 33: 4443-4450.
35. Wu C, Wang Z, Lei H, Duan Y, Bowers MT, et al. (2008) The Binding of Thioflavin T and Its Neutral Analog BTA-1 to Protofibrils of the Alzheimer's Disease Aβ16-22 Peptide Probed by Molecular Dynamics Simulations. J Mol Biol 384: 718-729.
36. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, et al. (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Struct Funct Bioinform 65: 712-725.
37. Jorgensen W, Chandrasekhar J, Madura J, Impey R, Klein M, (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935.
38. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, et al. (1995) A smooth particle mesh Ewald method. J Chem Phys 103: 8577-8593.
39. Ryckaert JP, Ciccotti G, Berendsen HJC, (1977) Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23: 327-341.
40. Berendsen HJC, Postma JPM, Van Gunsteren WF, DiNola A, Haak JR, (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81: 3684-3690.
41. Ou L, Luo Y, Wei G, (2011) Atomic-Level Study of Adsorption, Conformational Change, and Dimerization of an α-Helical Peptide at Graphene Surface. J Phys Chem B 115: 9813-9822.
42. Case D, Darden T, Cheatham III T, Simmerling C, Wang J, et al. (2008) AMBER 10. University of California, San Francisco.
43. Humphrey W, Dalke A, Schulten K, (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-38.
44. Frishman D, Argos P, (2004) Knowledge-based protein secondary structure assignment. Proteins: Struct Funct Bioinform 23: 566-579.
45. Moriarty DF, Raleigh DP, (1999) Effects of Sequential Proline Substitutions on Amyloid Formation by Human Amylin20-29. Biochemistry 38: 1811-1818.
46. Wu C, Lei H, Wang Z, Zhang W, Duan Y, (2006) Phenol Red Interacts with the Protofibril-Like Oligomers of an Amyloidogenic Hexapeptide NFGAIL through Both Hydrophobic and Aromatic Contacts. Biophys J 91: 3664-3672.
47. Wu C, Lei H, Duan Y, (2005) The Role of Phe in the Formation of Well-Ordered Oligomers of Amyloidogenic Hexapeptide (NFGAIL) Observed in Molecular Dynamics Simulations with Explicit Solvent. Biophys J 88: 2897-2906.
48. Wu C, Lei H, Duan Y, (2005) Elongation of Ordered Peptide Aggregate of an Amyloidogenic Hexapeptide NFGAIL Observed in Molecular Dynamics Simulations with Explicit Solvent. J Am Chem Soc 127: 13530-13537.
49. Wu C, Lei H, Duan Y, (2004) Formation of Partially Ordered Oligomers of Amyloidogenic Hexapeptide (NFGAIL) in Aqueous Solution Observed in Molecular Dynamics Simulations. Biophys J 87: 3000-3009.
50. Azriel R, Gazit E, (2001) Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide: AN EXPERIMENTAL SUPPORT FOR THE KEY ROLE OF THE PHENYLALANINE RESIDUE IN AMYLOID FORMATION. J Biol Chem 276: 34156-34161.
51. Melquiond A, Gelly J-C, Mousseau N, Derreumaux P, (2007) Probing amyloid fibril formation of the NFGAIL peptide by computer simulations. J Chem Phys 126: 065101-065107.
52. Zanuy D, Ma B, Nussinov R, (2003) Short Peptide Amyloid Organization: Stabilities and Conformations of the Islet Amyloid Peptide NFGAIL. Biophys J 84: 1884-1894.
53. Nielsen JT, Bjerring M, Jeppesen MD, Pedersen RO, Pedersen JM, et al. (2009) Unique Identification of Supramolecular Structures in Amyloid Fibrils by Solid-State NMR Spectroscopy. Angew Chem 121: 2152-2155.
54. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, et al. (2007) Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447: 453-457.
55. Jiang P, Li W, Shea J-E, Mu Y, (2011) Resveratrol Inhibits the Formation of Multiple-Layered β-Sheet Oligomers of the Human Islet Amyloid Polypeptide Segment 22-27. Biophys J 100: 1550-1558.
56. Yu X, Wang Q, Lin Y, Zhao J, Zhao C, et al. (2012) Structure, Orientation, and Surface Interaction of Alzheimer Amyloid-β Peptides on the Graphite. Langmuir 28: 6595-6605.
57. Ge C, Du J, Zhao L, Wang L, Liu Y, et al. (2011) Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci 108: 16968-16973.
58. Zuo G, Huang Q, Wei G, Zhou R, Fang H, (2010) Plugging into Proteins: Poisoning Protein Function by a Hydrophobic Nanoparticle. ACS nano 4: 7508-7514.
59. Fan W, Zeng J, Zhang R, (2009) Quantum Mechanical Quantification of Weakly Interacting Complexes of Peptides with Single-Walled Carbon Nanotubes. J Chem Theory Comput 5: 2879-2885.
60. Tomásio SM, Walsh TR, (2009) Modeling the Binding Affinity of Peptides for Graphitic Surfaces. Influences of Aromatic Content and Interfacial Shape. J Phys Chem C 113: 8778-8785.
61. Zuo G, Zhou X, Huang Q, Fang H, Zhou R, (2011) Adsorption of Villin Headpiece onto Graphene, Carbon Nanotube, and C60: Effect of Contacting Surface Curvatures on Binding Affinity. J Phys Chem C 115: 23323-23328.
62. Wang S, Humphreys ES, Chung S-Y, Delduco DF, Lustig SR, et al. (2003) Peptides with selective affinity for carbon nanotubes. Nat Mater 2: 196-200.
63. Zorbas V, Smith AL, Xie H, Ortiz-Acevedo A, Dalton AB, et al. (2005) Importance of Aromatic Content for Peptide/Single-Walled Carbon Nanotube Interactions. J Am Chem Soc 127: 12323-12328.